CCOC(=O)C1=C(C)C2C3C(=O)N(c4ccc(C)cc4C)C(=O)C3C1(C)C1C(=O)N(c3ccc(C)cc3C)C(=O)C21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?